152 related articles for article (PubMed ID: 34530564)
21. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
Chua YJ; Cunningham D
Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
[No Abstract] [Full Text] [Related]
22. The impact of the length of proximal margin on the prognosis in adenocarcinoma of gastroesophageal junction: A real-world study and strategies.
Pang T; Nie MM; Fan L; Wang JY; Liu ZR; Qin Y; Yin K
Asian J Surg; 2024 Jun; 47(6):2613-2622. PubMed ID: 38565445
[TBL] [Abstract][Full Text] [Related]
23. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.
Duan X; Shang X; Tang P; Jiang H; Yu Z
ANZ J Surg; 2018 Apr; 88(4):E264-E267. PubMed ID: 28503799
[TBL] [Abstract][Full Text] [Related]
24. Short- and Long-Term Outcomes of the Minimal Proximal Resection Margin in Total Gastrectomy for Siewert II Adenocarcinoma of the Esophagogastric Junction.
Guo W; Hao J; Mei X; Wang Y; He Z; Su S; Zhang K; Guan X; Yang J; Lv J
Am Surg; 2023 Dec; 89(12):5480-5486. PubMed ID: 36787579
[TBL] [Abstract][Full Text] [Related]
25. Results of the different surgical options for the treatment of cancer of the esophagogastric junction: Review of the evidence.
Munitiz V; Ortiz A; Ruiz de Angulo D; F Martinez de Haro L; Parrilla P
Cir Esp (Engl Ed); 2019 Oct; 97(8):445-450. PubMed ID: 31027834
[TBL] [Abstract][Full Text] [Related]
26. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.
Bissolati M; Desio M; Rosa F; Rausei S; Marrelli D; Baiocchi GL; De Manzoni G; Chiari D; Guarneri G; Pacelli F; De Franco L; Molfino S; Cipollari C; Orsenigo E
Gastric Cancer; 2017 Jan; 20(1):70-82. PubMed ID: 26732876
[TBL] [Abstract][Full Text] [Related]
27. [Proximal gastrectomy for adenocarcinoma of the gastroesophageal junction in a selected set of patients immediate and long-term results].
Vrba R; Aujeský R; Neoral Č; Stašek M; Loveček M; Tesaříková J; Vomáčková K; Horáková M; Zapletalová J
Rozhl Chir; 2016; 95(12):439-443. PubMed ID: 28182439
[TBL] [Abstract][Full Text] [Related]
28. Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study from SEER Database.
Wu D; Wang H; Xu BB; Lin J; Xue Z; Xu LL; Lu J
J Gastrointest Surg; 2023 Nov; 27(11):2592-2596. PubMed ID: 37507588
[No Abstract] [Full Text] [Related]
29. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Gabbani M; Grandinetti A; Tomezzoli A; Ruzzenente A; Guglielmi A; de Manzoni G
Chir Ital; 2005; 57(1):9-14. PubMed ID: 15832733
[TBL] [Abstract][Full Text] [Related]
31. Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma.
Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
Anticancer Res; 2015 Jan; 35(1):419-25. PubMed ID: 25550582
[TBL] [Abstract][Full Text] [Related]
32. [A Case of Advanced Adenocarcinoma at the Esophagogastric Junction That Exhibited pCR by Preoperative SOX Therapy].
Mihara D; Kuwada K; Hamazaki T; Namba K; Takahashi T; Takehara K; Kuise T; Kuroda M; Yamano T; Takagi S; Ikeda E; Kemmotsu M; Ikeda T
Gan To Kagaku Ryoho; 2022 Jun; 49(6):693-696. PubMed ID: 35799398
[TBL] [Abstract][Full Text] [Related]
33. Transthoracic Single-Port Assisted Laparoscopic Five-Step Maneuver Lower Mediastinal Lymphadenectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction.
Xiong W; Chen Y; Zhu X; Luo S; Peng Y; Li J; Zheng Y; Luo L; Cui Z; Wan J; Wang W
Ann Surg Oncol; 2022 Jun; 29(6):3936-3937. PubMed ID: 35279772
[No Abstract] [Full Text] [Related]
34. [Application and efficacy of double tract digestive reconstruction with jejunal interposition after proximal gastrectomy for Siewert II-III adenocarcinoma of esophagogastric junction].
Zhang ZY; Mao XJ; Jiang GB; Miao GG; Wei B; Deng YX; Leng JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):408-411. PubMed ID: 32306611
[No Abstract] [Full Text] [Related]
35. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
36. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
37. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
38. Near infrared ray-guided surgery using Firefly technology of the daVinci Xi system and intraoperative upper gastrointestinal endoscopy for subtotal gastrectomy and surgery for cancer of the gastroesophageal junction.
Sagawa H; Saito M; Ito S; Hayakawa S; Ueno S; Okubo T; Tanaka T; Ogawa R; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
BMC Surg; 2022 May; 22(1):174. PubMed ID: 35549907
[TBL] [Abstract][Full Text] [Related]
39. Comparison of long-term clinical outcomes between endoscopic and surgical resection for early-stage adenocarcinoma of the esophagogastric junction.
Kim HJ; Chung H; Shin SK; Kim HI; Park JC; Lee SK; Hyung WJ; Lee YC; Noh SH
Surg Endosc; 2018 Aug; 32(8):3540-3547. PubMed ID: 29417228
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
